Tonight on Nightly Business Report, Eli Lilly’s arthritis drug was expected to be a blockbuster, but the FDA said not so fast. Plus, why Americans are once again swimming in debt.
About NBR“Nightly Business Report produced by CNBC” (NBR) is an award-winning and highly-respected nightly business news program that airs on public television. Television’s longest-running evening business news broadcast, “NBR” features in-depth coverage and analysis of the biggest financial news stories of the day and access to some of the world’s top business leaders and policy makers.
- 9 best European retirement destinations
- Russia says Google down-ranking Sputnik, RT would be censorship
- Workers at Amazon's main Italian site to hold first strike on Black Friday
- What not to say when a hiring manager says, 'Tell me about a mistake you made.'
- Saudi Arabia has become an 'irrational actor in the Middle East,’ says analyst
NBR on TwitterMy Tweets
Subscribe to RSS